Antibodies to Neospora caninum were determined in serum samples from 282 stray cats coming from four colonies near Turin (north-west Italy). Sera were tested using a Neospora Agglutination Test (NAT). Scroprevalence was 24.8% at 1:80,12.8% at 1: 160 and 5.3% at 1:320 dilution. Seroprevalence in females and males, in different colonies and in different age classes, did not differ significantly. Our results confirm that domestic cats are exposed to N. caninum and the observed seroprevalences suggest that risk of exposure is high and N. caninum should be considered in differential diagnosis in cats with neurological signs. (c) 2005 Elsevier B.V. All rights reserved.

Antibodies to Neospora caninum in stray cats from north Italy

FERROGLIO, Ezio;PASINO, MARCO;TRISCIUOGLIO, Anna
2005-01-01

Abstract

Antibodies to Neospora caninum were determined in serum samples from 282 stray cats coming from four colonies near Turin (north-west Italy). Sera were tested using a Neospora Agglutination Test (NAT). Scroprevalence was 24.8% at 1:80,12.8% at 1: 160 and 5.3% at 1:320 dilution. Seroprevalence in females and males, in different colonies and in different age classes, did not differ significantly. Our results confirm that domestic cats are exposed to N. caninum and the observed seroprevalences suggest that risk of exposure is high and N. caninum should be considered in differential diagnosis in cats with neurological signs. (c) 2005 Elsevier B.V. All rights reserved.
2005
131 (1-2)
31
34
E Ferroglio; P Guiso; M Pasino; A Accossato; A Trisciuoglio
File in questo prodotto:
File Dimensione Formato  
Antibodies to N.caninum in stray cat.pdf

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 81.99 kB
Formato Adobe PDF
81.99 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/49598
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 23
social impact